Abiraterone/Prednisone, Olaparib, or Abiraterone/Prednisone + Olaparib in Patients With Metastatic Castration-Resistant Prostate Cancer With DNA Repair Defects

Weill Cornell Medical College, New York

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore

University of Virginia, Charlottesville

University of North Carolina at Chapel Hill, Chapel Hill

H. Lee Moffitt Cancer Center and Research Institute, Tampa

Indiana University/ Melvin and Bren Simon Cancer Center, Indianapolis

Karmanos Cancer Center, Detroit

Mayo Clinic, Rochester

Kellogg Cancer Center - NorthShore University, Evanston

Northwestern Medicine, Chicago

Rush University Cancer Center, Chicago

University of Chicago, Chicago

Washington University School of Medicine, St Louis

Huntsman Cancer Institute - University of Utah, Salt Lake City

University of California Los Angeles, Los Angeles

City of Hope National Medical Center, Duarte

University of Michigan Health System, Ann Arbor

Rutgers Cancer Institute of New Jersey, New Brunswick